The federal judge presiding over thousands of Actos lawsuits that are currently consolidated in a multi-district litigation (MDL) recently issued a handful of case management orders. The orders are an apparent attempt to streamline the large, complex litigation, encourage large-scale settlement, and prevent duplication of thousands of state court Actos... Read more »

The drug Actos has been on the market since 1999, and was once one of the highest-grossing type 2 diabetes drugs available. Developed by drug maker Takeda Pharmaceuticals, Actos is becoming increasingly linked with the onset of deadly bladder cancer – and plaintiffs across the United States are accusing Takeda... Read more »

Japan-based pharmaceutical giant Takeda currently faces more than 8,000 Actos lawsuits that accuse the company of concealing bladder cancer risks. Most of these complaints have been coordinated in Louisiana federal court, as a part of multidistrict litigation, where a landmark Actos lawsuit award was rendered in the case of Terrence... Read more »

Earlier this month, a 79-year-old Philadelphia woman received a $2 million Actos lawsuit award for her bladder cancer claim. The jurors, after deliberating for more than five hours, found that the manufacturer was liable for Frances Wisniewski’s bladder cancer because it failed to warn her doctors about the cancer risk.... Read more »

An Actos class action lawsuit filed in Louisiana will remain separate from coordinated proceedings currently underway in that court, a judge has ruled. U.S. District Judge Rebecca Doherty recently issued an order stating the case filed by a health care fund will remain separate from hundreds of claims currently pending in... Read more »

The judge in one of the early Actos bladder cancer trials has upheld a record-breaking $9 billion punitive damages award against Takeda Pharmaceuticals and Eli Lilly, who recently attempted to have the Actos lawsuit award thrown out. U.S. District Judge Rebecca Doherty ruled that the jurors who assigned the award... Read more »

In a recent, and ongoing, federal lawsuit involving the diabetes drug Actos, manufacturer Takeda is now facing significant sanctions from U.S. District Court Judge Rebecca F. Doherty after a finding that it engaged in intentional and unlawful destruction of evidence tending to show it had knowledge of the dangers of... Read more »

In the wake of an Actos bladder cancer lawsuit verdict in April of this year, Takeda Pharmaceuticals and its U.S. partner Eli Lilly are now seeking a new trial or a reversal of the judgment, which includes both $1.5 million in compensatory damages for the plaintiff and a combined $9... Read more »

Blue Cross/ Blue Shield of Massachusetts has taken legal action against pharmaceutical giant Takeda, claiming the company failed to warn consumers and the medical community about the association between Actos and bladder cancer. The healthcare provider is now seeking compensation for costs of bladder cancer treatment for hundreds of their... Read more »